Treatment regimens and disease activity could alter salivary myeloperoxidase levels in patients with inflammatory bowel diseases.
Nijakowski K, Motylewska B, Banasik E, Rutkowski R, Tsaryk V, Łuczak J, Korybalska K, Witowski J, Surdacka A, Eder P. Pol Arch Intern Med. 2024 Jan 29; 134(1). Epub 2024 Jan 2.